NASD · Healthcare · Medical Care Facilities · USA
DocGo Inc is a micro cap company (market value under $300 million) in the Medical Care Facilities industry.
DocGo provides healthcare services through a technology-enabled platform delivering medical care in patients' homes and workplaces, along with transportation solutions across multiple states and the United Kingdom. The company serves municipalities, hospital networks, health insurance providers, and employers through its vertically integrated model. DocGo operates three segments: Mobile Health Services, Transportation Services, and Corporate.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the DocGo Inc stock.
No reliable verdict: intrinsic value $1.17 per share, market price $0.18 (as of 2026-11-17).
Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $1.17: 7 times the price of $0.18. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
3 more funds hold it; the full list is part of the paid plan.
All 48 Medical Care Facilities stocks
We do not publish a verdict on DCGO. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $1.17: 7 times the price of $0.18. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-11-17 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $1.17: 7 times the price of $0.18. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.